Turning Point Therapeutics Reports Third-Quarter Financial Results, Provides Operational Updates

Go back to Turning Point Therapeutics Reports Third-Quarter Financial Results, Provides Operational Updates

Turning Point Therapeutics Inc. (TPTX) Misses Q3 EPS by 7c

November 9, 2021 4:41 PM EST

Turning Point Therapeutics Inc. (NASDAQ: TPTX) reported Q3 EPS of ($1.34), $0.07 worse than the analyst estimate of ($1.27). Revenue for the quarter came in at $460 thousand.

For earnings history and earnings-related data on Turning Point Therapeutics Inc. (TPTX) click here.

... More